A longevity biotech lab developing science-backed products for age-related health challenges.
We develop novel multi-compound formulations targeting longevity-associated decline and environmental stress. Every formulation is validated in living organisms before reaching market.
SCIENCE
In-house synergistic formulation development and in vivo validation
PRODUCTS
Six active programs targeting multiple human health areas
MARKET
Four billions affected by conditions not addressed by pharma
BUSINESS MODEL
B2C first, followed by licensing and platform royalties
Major health challenges affect billions of people — but they are not classified as diseases, remain unaddressed creating a massive unmet need.
- •Limited public funding for translational research of these conditions.
- •No financial incentive for pharma to invest in non-disease indications.
- •Wellness products are poorly validated and deliver limited biological impact.
Yet these challenges impact quality of life for billions of people — and there is no science-backed systemic solution.
A full-stack drug discovery biotech platform from health challenge to in vivo-validated formulations
We identify widespread non-disease health challenges affecting billions and develop proprietary in vivo models that replicate these conditions at the whole-body level.
Using scientific literature, proprietary datasets, and AI-driven tools, we identify and prioritize candidate compounds with the highest potential to modulate the targeted biology.
Candidates are tested in proprietary in vivo models. Validated compounds are combined into synergistic multi-compound formulations designed for systemic biological impact.
Powered by our proprietary in vivo validation platform
VivoXpand's validation backbone is VivoArchitect — the world's first Contract Research Organization specialized exclusively in longevity research in mice. Licensed, EU-compliant, and operating across Europe. This infrastructure enables fully in-house research and preclinical validation before market entry.
Longevity Studies in Mice · Founded 2024
One platform. Multiple health frontiers.
BluPill
Sexual Function & Longevity
Daily chewable tablet supporting longevity and long-term sexual vitality. Two distinct formulations: for women, designed to enhance arousal, lubrication, and sensitivity; and for men, designed to improve erection performance, arousal, and vascular function.
SiestaK
Sleep & Thermoregulation
Chewable tablet targeting heat-disrupted rest — an increasingly common and underserved condition in warm climates, where high temperatures impair sleep onset and recovery.
AlpineFlame
Cold Tolerance
Thermogenic gel designed to enhance resistance to low temperatures and physical performance in cold environments. Initially developed for outdoor sports enthusiasts.
Fertilia
Fertility Under Stress
Oral capsule formulation developed to improve fertility outcomes affected by age-related decline, environmental heat, and physiological stress.
PeeBlock
Urinary Urgency
Innovative oral formulation designed to reduce urinary urgency when restroom access is limited. Supports hydration balance and maintains comfort during travel, meetings, and events.
Capilliux
Hair Growth
Topical serum to accelerate hair growth and improve strength and density. Targeting follicle activation and hair cycle regulation.
Real biotechnology. Real-world health.
Most health products rely on anecdotal evidence, in vitro studies, and marketing. VivoXpand applies pharmaceutical preclinical standards of drug discovery, generating in vivo, whole-body scientific evidence before market entry.
Marketing-first development
External evidence based on in vitro/silico studies
Rely on a single-ingredient
Uncertain efficacy and long-term safety
Science-first development
In-house in vivo validation in proprietary models
Multi-compound synergistic formulations
Demonstrated efficacy and safety
A multidisciplinary co-founding team with complementary expertise
Alberto Parras
Ph.D. · Biotechnology
Director & Scientific Lead
Manuel León
MSc · Engineering
Technology Lead
Paulina Biniecka
Ph.D. · Cancer Biology
Strategy & Communications Lead
Hipólito Lobato
BSc · Biotechnology
Head of Product
Our goal is to redefine overlooked human health challenges that affect billions but remain ignored — bringing them to the same scientific standard as disease-based medicine.
Partner with us to bring validated health solutions to market
We work with investors, licensing collaborators, and research organizations
Direct contact